Literature DB >> 1490831

The rational selection of drug interaction studies: implications of recent advances in drug metabolism.

G T Tucker1.   

Abstract

Mesh：

Substances：

Year:  1992        PMID： 1490831

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Ther Toxicol        ISSN： 0174-4879


× No keyword cloud information.
  11 in total

1.  In vitro characterization of the human biotransformation pathways of aplidine, a novel marine anti-cancer drug.

Authors:  Esther F A Brandon; Rolf W Sparidans; Ronald D van Ooijen; Irma Meijerman; Luis Lopez Lazaro; Ignacio Manzanares; Jos H Beijnen; Jan H M Schellens
Journal:  Invest New Drugs       Date:  2007-02       Impact factor: 3.850

2.  In vitro characterization of the human biotransformation and CYP reaction phenotype of ET-743 (Yondelis, Trabectidin), a novel marine anti-cancer drug.

Authors:  Esther F A Brandon; Rolf W Sparidans; Kees-Jan Guijt; Sjoerd Löwenthal; Irma Meijerman; Jos H Beijnen; Jan H M Schellens
Journal:  Invest New Drugs       Date:  2006-01       Impact factor: 3.850

3.  Identification of the major human liver cytochrome P450 isoform(s) responsible for the formation of the primary metabolites of ziprasidone and prediction of possible drug interactions.

Authors:  C Prakash; A Kamel; D Cui; R D Whalen; J J Miceli; D Tweedie
Journal:  Br J Clin Pharmacol       Date:  2000       Impact factor: 4.335

Review 4.  Important drug interactions in dermatology.

Authors:  T C Roos; H F Merk
Journal:  Drugs       Date:  2000-02       Impact factor: 9.546

5.  Zolpidem metabolism in vitro: responsible cytochromes, chemical inhibitors, and in vivo correlations.

Authors:  L L Von Moltke; D J Greenblatt; B W Granda; S X Duan; J M Grassi; K Venkatakrishnan; J S Harmatz; R I Shader
Journal:  Br J Clin Pharmacol       Date:  1999-07       Impact factor: 4.335

6.  Nonspecific binding of drugs to human liver microsomes.

Authors:  J A McLure; J O Miners; D J Birkett
Journal:  Br J Clin Pharmacol       Date:  2000-05       Impact factor: 4.335

7.  Effects of anticancer drugs on the metabolism of the anticancer drug 5,6-dimethylxanthenone-4-acetic (DMXAA) by human liver microsomes.

Authors:  S Zhou; R Chin; P Kestell; M D Tingle; J W Paxton
Journal:  Br J Clin Pharmacol       Date:  2001-08       Impact factor: 4.335

Review 8.  Metabolism of drugs by cytochrome P450 3A isoforms. Implications for drug interactions in psychopharmacology.

Authors:  L L von Moltke; D J Greenblatt; J Schmider; J S Harmatz; R I Shader
Journal:  Clin Pharmacokinet       Date:  1995       Impact factor: 6.447

9.  Inhibitors of alprazolam metabolism in vitro: effect of serotonin-reuptake-inhibitor antidepressants, ketoconazole and quinidine.

Authors:  L L von Moltke; D J Greenblatt; M M Cotreau-Bibbo; J S Harmatz; R I Shader
Journal:  Br J Clin Pharmacol       Date:  1994-07       Impact factor: 4.335

10.  Inhibition of Efavirenz Metabolism by Sertraline and Nortriptyline and Their Effect on Efavirenz Plasma Concentrations.

Authors:  Virginia Melis; Iris Usach; Patricia Gandía; José-Esteban Peris
Journal:  Antimicrob Agents Chemother       Date:  2015-12-07       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.